S Erdmann1, M Hertl, H F Merk. Show Affiliations » 1. Department of Dermatology, University Hospitals RWTH Aachen, Germany.
Abstract
Entities: Chemical Disease
Mesh： See more » Adrenergic beta-Antagonists/adverse effectsAdrenergic beta-Antagonists/therapeutic useAgedBlepharitis/chemically inducedDermatitis, Allergic Contact/diagnosisDermatitis, Allergic Contact/etiologyFemaleGlaucoma, Open-Angle/drug therapyHumansLevobunolol/adverse effectsLevobunolol/therapeutic useOphthalmic Solutions/adverse effectsPatch Tests
Substances： See more » Adrenergic beta-AntagonistsOphthalmic SolutionsLevobunolol
Year: 1999 PMID： 10416712 DOI： 10.1111/j.1600-0536.1999.tb06211.x
Source DB: PubMed Journal: Contact Dermatitis ISSN： 0105-1873 Impact factor: 6.600